The Business
Research Company published its Gene Therapy Global Market Report 2020 which
provides strategists, marketers and senior management with the critical
information they need to assess the global Gene Therapy market. The report
provides in-depth analysis of the impact of COVID-19 on the market, along with
revised market numbers due to the effects of the coronavirus.
The report covers the Gene Therapy market’s
segments-
1) By Gene
Type: Antigen, Cytokine, Suicide Gene, Others
2) By
Vector: Viral Vector, Non-Viral Vector, Others
3) By
Application: Oncological Disorders, Rare Diseases, Cardiovascular Diseases,
Neurological Disorders, Infectious Diseases, Others
4) By End
Users: Hospitals, Homecare, Specialty Clinics, Others.
View Complete Report:
Gene Therapy Global Market Report 2020 is the most
comprehensive report available on this market and will help gain a truly global
perspective as it covers 60 geographies. The chapter on the impact of COVID-19
gives valuable insights on supply chain disruptions, logistical challenges, and
other economic implications of the virus on the market. The chapter also covers
markets which have been positively affected by the pandemic.
The global gene therapy market is expected to decline from
$3.22 billion in 2019 to $3.18 billion in 2020 at a compound annual growth rate
(CAGR) of -1.30%. The decline is mainly due to the COVID-19 outbreak that has
led to restrictive containment measures involving social distancing, remote
working, and the closure of industries and other commercial activities
resulting in operational challenges. The market is then expected to recover and
reach $6.84 billion in 2023 at a CAGR of 29.09%.
The use of machine learning and artificial intelligence is
gradually gaining popularity in the gene therapy market. Artificial
intelligence (AI) is the simulation of human intelligence in machines, which
are programmed to display their natural intelligence. Machine learning is a
part of AI. Machine learning and AI help companies in the gene therapy market
to conduct a detailed analysis of all relevant data, provide insights between
tumor and immune cell interactions, and offer a more accurate evaluation of
tissue samples often conflicted between different evaluators.
Few Points From Table Of Content
1. Executive
Summary
2. Gene
Therapy Market Characteristics
3. Gene
Therapy Market Size And Growth
4. Gene
Therapy Market Segmentation
5. Gene
Therapy Market Regional And Country Analysis
.....
25. Gene
Therapy Market Competitive Landscape And Company Profiles
26. Key
Mergers And Acquisitions In The Gene Therapy Market
27. Gene
Therapy Market Trends And Strategies
28. Gene
Therapy Market Future Outlook and Potential Analysis
29. Appendix
Request A Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp
Few Points From List
Of Tables
Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2019, 2023F,
2025F, 2030F, $ Billion
Table 3: Global Gene Therapy Market, Segmentation By Gene
Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 4: Global Gene Therapy Market, Segmentation By Vector,
Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
………
Table 48: Bluebird Bio, Inc. Financial Performance
Table 49: Spark Therapeutics, Inc. Financial Performance
Table 50: Audentes Therapeutics Financial Performance
Table 51: Voyager Therapeutics Financial Performance
About The Business
Research Company:
The Business
Research Company is a Business Intelligence Company which excels in company,
market and consumer research. It has offices in the UK, the US and India and a
network of trained researchers in 52 countries globally.
Contact Information:
The Business Research
Company
Europe: +44 207 1930
708
Asia: +91 8897263534
Americas: +1 315 623
0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
